#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rhabdomyosarcoma recurrent Thrombotic thrombocytopenic purpura Pleural mesothelioma Pemphigoid Neuroendocrine tumour of the lung Congenital absence of bile ducts Autoimmune hepatitis Chronic granulomatous disease Malignant oligodendroglioma Oesophageal squamous cell carcinoma stage III Fms-like tyrosine kinase 3 positive Cervix carcinoma recurrent B-cell small lymphocytic lymphoma Ovarian cancer stage III Liver abscess More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Pemphigoid – Basic Information Advanced systemic mastocytosis Mantle cell lymphoma stage III – Life with Disease Gaucher’s disease type I Glomerulonephritis rapidly progressive – Treatment Castleman’s disease – Treatment Congenital hypotransferrinaemia – Trials in Disease Idiopathic pulmonary fibrosis – Life with Disease Ornithine transcarbamoylase deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000040033 Linrodostat Mesilate Eribulin Cefepime ATIRMOCICLIB Antithrombin Iii Human Interleukin-1 Vildagliptin Codeine Phosphate Hemihydrate Sodium Iodide (123 I) Vibosameran Lenomorelin Rifaximin Danicamtiv Intestifix Sotalol Hydrochloride Mitoxantrone Db-Oto-3 Ly3484356 FRUQUINTINIB More therapies…

    Learn about Your Condition

    Neuroblastoma Malignant melanoma stage II Vesicoureteric reflux Carcinoid tumour pulmonary Vulvovaginal discomfort Arterial disorder Suicidal ideation Exfoliation glaucoma Guttate psoriasis Burkitt's lymphoma Cardiac failure congestive Spinal muscular atrophy Postoperative delirium Pre-eclampsia Dermatitis atopic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pauls Stradins Clinical University Hospital

Pauls Stradins Clinical University Hospital

Pilsonu Iela 13, Riga, 1002, Latvia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis relapse
    Investigated Drugs:
    • A/Darwin/6/2021(H3N2)-Like Strain (A/Darwin/11/2021, Wild Type)
    • A/Wisconsin/67/2022 (H1N1)Pdm09-Like Strain (A/Georgia/12/2022 Cvr-167)
    • B/Austria/1359417/2021-Like Strain (B/Singapore/Wuh4618/2021)
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Abelacimab
    • Apixaban
    Austria Czechia France Germany Hungary Ireland +6

  • Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Embolism venous
    • Gastrointestinal cancer metastatic
    Investigated Drugs:
    • Abelacimab
    • Dalteparin Sodium
    Austria Czechia France Germany Hungary Ireland +6

  • Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ustekinumab
    • Guselkumab
    Belgium Croatia Czechia France Germany Hungary +7

  • Study on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Poloxamer 407
    Bulgaria Estonia Latvia Romania Spain

  • Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Chloride
    • Vedolizumab
    Bulgaria Croatia Czechia Greece Hungary Italy +5

  • Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Roflumilast
    • Tanimilast
    Austria Bulgaria Croatia Czechia Estonia Germany +8

  • Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Amikacin Sulfate
    • Aztreonam
    • Cefepime
    Croatia Czechia France Greece Latvia Slovakia +1

  • Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Omalizumab
    Bulgaria Hungary Latvia Lithuania Poland Slovakia

  • Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Vascular Endothelial Growth Factor Receptor 3 Extracellular Domains 1-3 Fused To A Igg1 Fc Fragment
    • Aflibercept
    Austria Bulgaria Croatia Czechia Estonia France +10
Previous Page
1 … 6 7 8 9 10 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!